RxDoctor Payments Data

David Cortese, MD

Orthopaedic Surgery · Enumclaw, WANPI 1710098660

Payments from drug & device makers

$12,380in general payments, 2019–2025

Across 72 payments — averaging $171.94 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Summit Surgical Corp.$5K
  • Arthrex$2K
  • Zimmer Biomet$1K
  • Smith+Nephew$1K
  • Stryker$1K
  • Invictus Surgical Incorporated$931
  • plus $200 from 2 others

What the payments were for

  • Travel & lodging$5,92648%
  • Food & beverage$2,85423%
  • Education$3,60029%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Summit Surgical Corp.10$5,110
Arthrex30$2,454
Zimmer Biomet13$1,331
Smith+Nephew9$1,247
Stryker5$1,107
Invictus Surgical Incorporated3$931
Miach Orthopaedics, Inc.1$185
KCI USA, Inc.1$15

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$12,380 in reported general payments places this provider in the 75th percentile of 495 orthopaedic surgery providers in Washington.

See all orthopaedic surgery providers in Washington

Medicare billing

Part B allowed, 2024
$163,309
Medicare patients
409
Services billed
3,807

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Celecoxib16$560
Diclofenac Sodium23$318
Ondansetron OdtOndansetron20$212
Meloxicam100$183
Oxycodone Hcl39$181
Naproxen13$109
Hydroxyzine Hcl15$85
Gabapentin26$84
Cefadroxil12$63
Amoxicillin13$23

Paid to pharmacies, not to this prescriber.

Other orthopaedic surgery in Enumclaw

See the full list for Washington

Where these figures come from

Is this you, or does something look wrong? →